Prescient ushers in “next gen” immunotherapy cancer platform
ASX listed biotech company Prescient Therapeutics (ASX: PTX) has this week unveiled two significant licence agreements that forms
News
options
News
Business lending adapts to a digital-first world
COVID-19 has put many SMEs under existential threat. In reaction to the current climate, some lenders have seen
News
Changing retail habits: Facebook vs Amazon
Along with a multitude of other habits of our lives, retail habits have dramatically changed during the pandemic.
News
Could the crisis change how cities operate?
COVID-19 has dramatically changed our everyday habits. We’ve further adopted a digital-first lifestyle and have now found ways
News
The outlook for independent superannuation trustees post Royal Commission
The Australian superannuation industry consists of five different types of superannuation funds; Industry funds, Public sector funds, retail
News
How to benefit from an unpredictable market
COVID-19 has not only caused fear, shock and volatility to rip through the market, but has also pulled
News
Is this the perfect storm for Warren Buffett?
This week we were joined in office by Prescient Therapeutics (ASX: PTX) CEO and Managing Director Steven Yatomi-Clarke
News
Reach Corporate: Helping companies and corporate advisers engage effectively with investors
CEOs and advisers must get ready for new ways of working. Businesses are starting to understand that as
News
Where is the Australian Iron Ore industry headed now that COVID-19 has changed the world?
The Australian iron ore sector emerges from COVID-19 with opportunities to expand and diversify, but Chinese boycott remains
News
New podcast series: Professional traders on strategy, current trades and the market
We are converting our webcasts into podcasts so you can consume them at your leisure.